Introduction
O'nyong-nyong (ONN) virus is a mosquito-borne alphavirus that, during 1959-1962, caused a major central African epidemic that began in northern Uganda and involved an estimated 2 million patients in Kenya, Tanzania, and Uganda alone.' This self-limiting and previously unknown disease was characterized by debilitating polyarthralgia, often accompanied by skin rash and lymphadenitis.
2 During 1959 During -1962 , 46 strains of ONN vims were isolated from acutely ill patients in 15 locations in Uganda, Kenya, and Tanzania. 1 Although no fatal cases of ONN fever were documented, the epidemic was associated with substantial morbidity. Labor-intensive production and agricultural industries were significantly affected in some areas, with 25% or more of the labor force -often 10% at one time -missing at least 5 days of work. 3 Two of the region's major malaria vectors, Anopheles gambiae and
An. funestus, were implicated as the primary epidemic vectors of this virus. 4 5 Although the epidemic waned in Uganda during 1961, ONN fever cases were documented in an area extending from Mozambique to Senegal during 1960-1962. 6 In 1978, a strain of ONN virus was isolated from An. funestus collected in western Kenya. 7 Although no cases of ONN fever were documented after 1962, results of seroprevalence studies suggested that sporadic human infections with ONN virus continued to occur within the region. 8 9 10 " The enzootic vectors and natural reservoir hosts of ONN virus remain unknown.
In mid-1996, following an apparent absence of approximately 35 years, the first recognized re-emergence of ONN fever occurred in south-central Uganda. 12 The earliest cases were noted in the mostly rural Rakai District. Within a few weeks, the epidemic had extended to portions of the adjacent Masaka and Mbarara districts. Vertebrate studies conducted during the epidemic failed to incriminate rodents or mongooses as amplifying hosts of the virus. 13 Although a strain of ONN virus was isolated from Mansonia uniformis mosquitoes, An.
funestus was implicated as the primary epidemic vector. 14 Results of molecular virologie studies suggested that a single genotype of ONN virus circulated during this epidemic, and indicated that this genotype shared a high degree of genetic and protein sequence homology with an ONN virus strain isolated in northern Uganda in 1959 during the previous epidemic. 15 This paper provides a general description of the 1996-1997 epidemic and results of a serologic and virologie survey of humans conducted during January and early February 1997 in the affected region. A more detailed description of clinical features and an analysis of the utility of a purely clinical case definition for surveillance purposes will be published separately (Chapter 6).
Methods
Description of the epidemic area. The Rakai District, with a 1997 population of-444,500, is irregularly shaped with a surface area of -4,100 square km, and lies just below the equator. Lake Victoria and Tanzania form its eastern and southern borders, respectively (figure 1 Active case finding
For purposes of this study, a presumptive clinical case of ONN fever was defined as an acute febrile illness with polyarthralgia occurring within the previous 9 months (May 1996
to February 1997).
Two teams of researchers surveyed the Rakai District and adjacent portions of the Masaka and Mbarara districts region during January 23-25, 1997. In selected towns or villages, village leaders, health-care workers, folk medicine practitioners, druggists, and other inhabitants were questioned about the occurrence in their area of a disease matching the description of ONN fever. The term "o'nyong-nyong" derives from a northern Ugandan dialect' 6 and is generally meaningless in southern Uganda, where more common local terms for ONN fever included "kyikonyogo" (roughly translated as "beaten on the joints with a stick") and "kyikutiiya". Informational leads were pursued and persons meeting the clinical case definition were located, interviewed, and sometimes bled. In this manner, major North-South and East-West transects of the Rakai District and adjacent portions of the adjacent Masaka and Mbarara districts were crudely sampled.
Selection of study sites
Four sites were selected for more intensive study: two sites at which cases (either current, recent, or both) meeting the clinical case definition of ONN fever were relatively abundant ("affected sites"), and two comparison sites at which few, if any, such cases were reported.
One affected site (Site #1 ) included two villages located on the shores of Lake Kijanebalola, Laboratory methods
These have been described in detail elsewhere (Chapter 6). Briefly, selected serum specimens were cultured for viruses by inoculation onto Vero cell monolayers or into suckling mice, 18 or tested for the presence of ONN viral RNA by the reverse-transcriptase polymerase chain reaction (RT-PCR), or both. All virus isolates were identified by both an immunofluorescent assay 19 and by RT-PCR.
Following the completion of virus isolation attempts and PCR tests, all serum specimens of sufficient quantity were heat-inactivated at 56°C for 30 minutes and then tested by by IgG EIA were then tested by a serum-dilution plaque-reduction neutralization (N) assay 20 in Vero cells using 90% plaque-reduction as a positive cutoff value. Specimens tested by N were screened at a 1:10 dilution against ONN virus (strain MP30, passage level 8), as well as against two other alphaviruses known to infect humans in Uganda and to crossreact serologically with ONN virus, i.e., CHIK (prototype strain S 27, high passage) and Sindbis (SIN, prototype strain Ar 339, passage level 14) viruses. 21 Using serial 2-fold dilutions, endpoint N titers were then determined for specimens that gave positive screening N results against one or more of these viruses.
Case definitions
A laboratory-confirmed ONN virus infection was defined by one or more of the following:
virus isolation, a positive IgM EIA, or a positive convalescent-phase serum N titer (>10) to ONN virus that was >4-fold higher than the corresponding N titer to CHIK virus. Similarly, a confirmed case of ONN fever was defined by laboratory confirmation and meeting the above clinical criteria for presumptive ONN fever (i.e., a history of an acute febrile illness with polyarthralgia within the previous 9 months). Individuals who met these laboratory criteria but not these clinical criteria were considered to have had inapparent ONN virus infections.
ONN virus infections in humans commonly result in the development of similar titers of N antibodies against both ONN virus and the closely related CHIK virus. 22 Therefore, a laboratory-presumptive ONN virus infection was defined by a positive convalescent-phase serum N titer to ONN virus that differed by <2-fold from the corresponding N titer to CHIK virus; a laboratory-presumptive ONN fever case was defined by meeting these serologic criteria and the above clinical criteria.
Statistical methods
Using Epilnfo software version 6.04b (Epidemiology Program Office, CDC, Atlanta, Georgia), the %2 test with Yates's correction or the two-tailed Fisher's exact test was used to compare pairs of proportions, the j2 test for trend was used to evaluate series of proportions, and the Wilcoxon two-sample test was used to compare the age distributions of two populations. In all statistical tests, P < 0.05 was considered to be significant.
Results
A total of 244 persons participated in the serosurvey, including 129 from the affected study sites (#1-2) and 115 from the comparison sites (#3-4). The survey response rate was 62% (129/207) of household members in the affected study sites, 45% (115/256) in the comparison sites, and 53% (244/463) overall. Very few households refused to participate in the survey. Nonrespondents mainly included children who went to school and adult males, who had responsibilities away from the household. In addition, an unknown number of children aged <3 years were excluded from participation. The subsamples of 129 and 115 persons, respectively, were similar in terms of age and sex distribution, each with a median age of 18.5 to 20 years and a modest predominance of females; however, the two subsamples differed significantly in terms of serologic results ( %2 test) . Therefore, the 36 laboratory-confirmed and the 22 laboratory-presumptive ONN virus infections were combined for further analysis, as were the 25 laboratory-confirmed and the 12 laboratory-presumptive ONN fever cases. These combined totals gave an estimated infection rate of 45% (58/129), an estimated attack rate of 29% (37/129), and an estimated apparent-to-inapparent infection ratio of 1.8(37/ [58-37]). The infection rate among females was higher than that among males, but the difference was not significant (35/71 or 49% vs. 23/58 or 40%, respectively, p=0.4by %2).
Infection rates were inversely related to age, but this trend did not reach statistical significance (p=0.2, yl test for trend; figure 2). The attack rate among females was higher than that among males, but the difference was not significant (24/71 or 34% vs. 13/58 or 22%, respectively, p=0.2 by %2). Attack rates were not significantly related to age (p=0.1, %2 test for trend; figure 2 ).
Among the 58 persons with laboratory-confirmed or -presumptive ONN virus infections at study sites #1 and #2, the median age was 15 years (range, 3-91) and 35 (60%) were females. Among the 37 laboratory-confirmed or -presumptive ONN fever cases, the median infected with ONN virus, and 12 (55%) had had at least 1 member with ONN fever (table 2) .
At this site, the epidemic evidently started in May 1996, peaked in August 1996, and continued at least into January 1997 (figure 3B).
At study site #2, an infection rate of 23% (1 5/66), an attack rate of 17% (11/66), and an apparentinapparent infection ratio of 2.8 (11/4) were estimated. Of 18 households sampled at Site #2, 10 (56%) had had at least 1 member infected with ONN virus, and 7 (39%) had had at least 1 member with ONN fever (table 2) . At this site, the epidemic evidently started in September 1996 and continued at least into early 1997 ( figure 3B ).
Of the 115 individuals sampled from 35 households at comparison study sites #3 and 
Discussion
This ONN fever epidemic, the second ever described, evidently began during mid-1996 in villages situated along the southern shore of Lake Kijanebalola in the Rakai District and then, over a period of months, extended to other south-central Ugandan villages situated near lakes and swamps. Anecdotal reports suggested that this epidemic was triggered by the northward movement of a viremic person or persons from nearby Tanzania, but this was never confirmed. Thus, an explanation for the re-emergence of epidemic ONN fever in Uganda after an apparent 35-year absence is elusive. Even the most rudimentary understanding of the origins of ONN fever epidemics and endemic cases (if they occur) will await the elucidation of the natural history of ONN virus, including its enzootic cycles, reservoirs, and inter-epidemic vectors.
The previous ONN fever epidemic in Uganda evolved into a major regional epidemic that swept across much of Central Africa over more than a 2-year period, 3 In the current study, large differences in infection and attack rates between ONN feveraffected study sites and comparison sites were documented. In affected areas, the estimated overall ONN virus infection rate and ONN fever attack rate were 45% and 29%, respectively.
In comparison areas, only 1 recent ONN virus infection was documented (based on the presence of IgM antibody) and no recent clinical ONN fever cases were identified. In one instance, the distance between an affected site (#1 ) and a comparison (#3) site was only a few kilometers. These marked geographic differences in human infection rates presumably reflect the relative proximity to larval habitat of An. funestus, the most likely primary vector of ONN virus in this epidemic. 14 Larvae of this mosquito species are found most commonly in larger bodies of clear, permanent water, such as lake shores, river margins, and swamps. If ONN virus was endemic in south-central Uganda during the inter-epidemic period, an increasing prevalence of N antibodies to ONN virus associated with increasing age would be expected among persons born after the previous ONN fever epidemic had ended and who had no recent illnesses suggestive of ONN fever. However, among the 62 persons sampled in the current study from ONN fever-affected study sites (#1 and #2) and who were tested for N antibody to ONN virus, who had no recent illnesses suggestive of ONN fever, and who were born after 1962, seroprevalence actually decreased with increasing age, although the trend was not statistically significant (data not shown). These data are difficult to interpret, however, because individuals who were infected during the interepidemic period are impossible to distinguish from those subclinical^ infected during the recent epidemic. Furthermore, the serosurvey response rate was 62% (129/207), which may have biased survey results (see below).
In the current study, an apparent-to-inapparent infection ratio of 1.8 (37/21) was estimated. During the previous ONN fever epidemic in Uganda, an apparent-to-inapparent infection ratio of 4 (25/6) was estimated, also based on a retrospective study design. 22 Such a relatively minor -and statistically insignificant -difference could be attributable to differences in the clinical case definitions used. For example, Williams and colleagues 22 considered as clinical cases all study subjects who said they had suffered from "ONN fever"
(with or without joint pain). This definition is somewhat more liberal than the clinical case definition used in the current study, which required the presence of joint pain as well as fever. Obviously, for many infectious diseases including ONN fever, apparent-to-inapparent infection ratios are difficult to estimate accurately, especially from retrospective studies, and depend largely on how clinical cases are defined. They also depend on the accuracy of clinical information, such as self-reports of fever, which can be unreliable. 27 Nevertheless, among those alphaviruses that typically cause self-limited diseases characterized by fever and joint pain, apparent-to-inapparent infection ratios of 1 or more are not unusual. For example, estimates of apparent-to-inapparent infection ratios were 4 for Mayaro virus 28 and from 0.02 to 3 for Ross River virus. 29 The current study has several limitations. First, the study was undertaken when the epidemic was waning in most affected villages in the midst of a dry season, and thus a largely retrospective design was necessary. Consequently, among a population experiencing frequent self-limited febrile illnesses, study participants were asked to recall details of an illness that occurred as many as 9 months previously. Secondly, ONN fever has never been well-studied in a prospective manner, and thus the optimal clinical case definition has yet to be determined. And although the case definition used in the current study (fever with joint pain) was probably highly sensitive, it may have been relatively nonspecific (Chapter 6). For these reasons, some misclassification of clinical cases in each direction undoubtedly occurred, and this could have affected estimates of clinical attack rates and apparent-to-inapparent infection ratios. Finally, the overall serosurvey response rate of 53% (244 of 463 household members) is low and, anecdotally, we observed that more adult males than females refused participation in the study. Young children are under-represented in the sample as well.
Whether or not this biased the survey results is unknown, but they should be interpreted cautiously nonetheless.
With the possible exception of the routine use of mosquito bed nets (which was denied by virtually all 244 persons sampled in the present study; data not shown), no practical measures currently exist for the widespread prevention and control of ONN fever or other diseases transmitted by An. funestus and An. gambiae. Housing and living conditions common to the region make widespread vector exclusion measures impractical in the short term. Poverty and remoteness of many villages work against the widespread availability of insect repellents. No vaccine against ONN virus exists. Anecdotal reports suggest that patients who developed apparent ONN fever in the Rakai District in 1996-1997 were often initially misdiagnosed with, and treated for, malaria. Thus, the cornerstone of an appropriate public health response to an epidemic of ONN fever generally should be the ascertainment of the geographic distribution and movement of the epidemic, and the dissemination of accurate information concerning the clinical and diagnostic features of the illness, the lack of specific treatment options, and the proper application of personal preventive measures.
Communication between public health officials in neighboring countries in the region is essential.
